HopeStage
Back to all studies
RecruitingNCT07633626

Vortioxetine and thinking changes during lung cancer treatment

About this titleRead the official source — NCT07633626
Observational studyAges 18+ColombiaDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
BogotáSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 10, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
24
Sponsor
Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Interview / survey / observational
Locations
Colombia
Age range
Over 18 Years
Official registry ID
NCT07633626
Official title
Show the full official title

Potential Effect of Vortioxetine on Cognitive Functioning of Patients With ALK-positive Non-Small Cell Lung Cancer Treated With Lorlatinib

Recruitment & locations

Currently recruiting

Bogotá

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies